Li-li Liu

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma.

Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma
Published: February 19, 2025

Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis.

Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis.

Journal: Cancer letters
Published: June 30, 2021

Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma.

Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma.

Journal: Frontiers in cell and developmental biology
Published: October 13, 2020

α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.

α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.

Journal: British journal of cancer
Published: October 06, 2020

Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.

Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.

Journal: Pathology, research and practice
Published: May 28, 2020

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.

Journal: Cancer immunology, immunotherapy : CII
Published: May 11, 2020

Thoughts on and Construction of a Risk Management and Control System for Contaminated Sites in the Guangdong-Hong Kong-Macao Greater Bay Area

Thoughts on and Construction of a Risk Management and Control System for Contaminated Sites in the Guangdong-Hong Kong-Macao Greater Bay Area

Journal: Huan jing ke xue= Huanjing kexue
Published: December 20, 2019

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.

Journal: Molecular oncology
Published: May 28, 2019

A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection.

A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection.

Journal: Cancer management and research
Published: October 06, 2018

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

Journal: Cancer management and research
Published: August 14, 2018

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.

Journal: Cancer research
Published: July 31, 2018

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.

Journal: Cancer management and research
Published: July 10, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026